<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2012</study_start_year><condition>Familial adenomatous polyposis</condition><condition>Cancer-Bowel-Back passage (rectum) or large bowel (colon)</condition><condition>Human Genetics and Inherited Disorders-Other human genetics and inherited disorders</condition><condition>Oral and Gastrointestinal-Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</condition><condition>Adenomas incidence in rectal stumps and ileal pouches</condition><disease>Oral And Gastrointestinal-other Diseases Of The Mouth, Teeth, Oesophagus, Digestive System Including Liver And Colon</disease><disease>Adenomas Incidence In Rectal Stumps And Ileal Pouches</disease><disease>Human Genetics And Inherited Disorders-other Human Genetics And Inherited Disorders</disease><disease>Cancer-bowel-back Passage (rectum) Or Large Bowel (colon)</disease><disease>Familial Adenomatous Polyposis</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2457717</full_dataset_link><location>Portugal</location><study_start_month>6</study_start_month><repository>ECRIN MDR</repository><study_status>Not yet recruiting</study_status></additional><is_claimable>false</is_claimable><name>Effect of topical mesalazine over adenomas incidence in rectal stumps and ileal pouches of familial adenomatous polyposis patients submitted to colectomy.</name><description>Interventions: Mesalazine, 1g per day of rectal foam, for 12months
Primary outcome(s): New adenomas (larger than 5mm) incidence in the rectal stumps or ileal pouches, as assessed by endoscopy[At study entry and six and twelve months after mesalazine use]
Study Design: Purpose: Prevention; Allocation: Non-randomised trial; Masking: Open (masking not used);Assignment: Single group;Type of endpoint: Efficacy</description><dates><creation>2012-06-15</creation></dates><accession>2457717</accession><cross_references><Australian New Zealand Clinical Trials Registry>ACTRN12611001281987</Australian New Zealand Clinical Trials Registry></cross_references></HashMap>